XML 61 R23.htm IDEA: XBRL DOCUMENT v2.4.0.8
Income Taxes
9 Months Ended
Sep. 30, 2014
Income Taxes  
Income Taxes

Note 16 Income Taxes

 

Income tax expense (benefit) for year to date September 30, 2014 and September 30, 2013 was as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

September 30, 2014

    

September 30, 2013

Current federal

 

$

(62)

 

$

129 

Current state

 

 

(17)

 

 

35 

Deferred federal

 

 

3,017 

 

 

2,935 

Deferred state

 

 

1,046 

 

 

1,049 

Change in valuation allowance

 

 

 -

 

 

(74,145)

 

 

$

3,984 

 

$

(69,997)

 

The following were the components of the deferred tax assets and liabilities as of September 30, 2014 and December 31, 2013:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    

September 30, 2014

    

December 31, 2013

Allowance for loan losses

 

$

10,648 

 

$

12,725 

Deferred compensation

 

 

798 

 

 

788 

Amortization of core deposit

 

 

1,993 

 

 

1,656 

Goodwill amortization/impairment

 

 

14,042 

 

 

15,252 

Stock option expense

 

 

642 

 

 

583 

OREO write downs

 

 

8,901 

 

 

10,041 

Federal net operating loss (“NOL”) carryforward

 

 

27,882 

 

 

28,023 

State net operating loss (“NOL”) carryforward

 

 

11,768 

 

 

11,847 

Deferred tax credit

 

 

1,453 

 

 

1,444 

Other assets

 

 

983 

 

 

1,166 

Total deferred tax assets

 

 

79,110 

 

 

83,525 

 

 

 

 

 

 

 

Accumulated depreciation on premises and equipment

 

 

(834)

 

 

(1,035)

Accretion on securities

 

 

(31)

 

 

(8)

Mortgage servicing rights

 

 

(2,491)

 

 

(2,571)

State tax benefits

 

 

(6,667)

 

 

(6,994)

Other liabilities

 

 

(411)

 

 

(178)

Total deferred tax liabilities

 

 

(10,434)

 

 

(10,786)

Net deferred tax asset before valuation allowance

 

 

68,676 

 

 

72,739 

Tax effect on net unrealized losses on securities

 

 

5,062 

 

 

4,927 

Valuation allowance

 

 

(2,363)

 

 

(2,363)

Net deferred tax asset

 

$

71,375 

 

$

75,303 

 

At September 30, 2014, the Company had  a $79.7 million federal net operating loss carryforward of which, $24.4 million expires in 2030, $31.4 million expires in 2031,  $8.6 million expires in 2032, and $15.3 million expires in 2033.  The Company had  a $123.9 million state net operating loss carryforward of which, $28.2 million expires in 2021, and $95.7 million expires in 2025.  In addition, the Company had  a $1.5 million alternative minimum tax credit subject to indefinite carryforward.

 

The components of the provision for deferred income tax expense (benefit) were as follows:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    

September 30, 2014

    

September 30, 2013

Allowance for loan losses

 

$

2,077 

 

$

4,536 

Deferred Compensation

 

 

(10)

 

 

(40)

Amortization of core-deposit

 

 

(337)

 

 

(519)

Stock option expense

 

 

(59)

 

 

177 

OREO write-downs

 

 

1,140 

 

 

5,560 

Federal net operating loss carryforward

 

 

141 

 

 

(5,634)

State net operating loss carryforward

 

 

79 

 

 

(1,248)

Deferred tax credit

 

 

(9)

 

 

 -

Depreciation

 

 

(201)

 

 

(117)

Net premiums and discounts on securities

 

 

23 

 

 

(109)

Mortgage servicing rights

 

 

(80)

 

 

596 

Goodwill amortization/impairment

 

 

1,210 

 

 

1,151 

State tax benefits

 

 

(327)

 

 

(333)

Change in valuation allowance

 

 

 -

 

 

(74,145)

Other, net

 

 

416 

 

 

(36)

Total deferred tax expense

 

$

4,063 

 

$

(70,161)

 

Effective tax rates differ from federal statutory rates applied to financial statement income (loss) due to the following:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

    

September 30, 2014

    

September 30, 2013

Tax at statutory federal income tax rate

 

$

3,896 

 

$

4,156 

Nontaxable interest income, net of disallowed interest deduction

 

 

(182)

 

 

(183)

BOLI income

 

 

(360)

 

 

(553)

State income taxes, net of federal benefit

 

 

606 

 

 

780 

Change in valuation allowance

 

 

 -

 

 

(74,145)

Deficiency from restricted stock

 

 

 -

 

 

10 

Other, net

 

 

24 

 

 

(62)

Tax at effective tax rate

 

$

3,984 

 

$

(69,997)